Skip to main content

Cutting-edge metastasis prediction algorithm can accurately predict the spread of cancer

Can cell phones cause brain cancer? We asked the experts
Predicting how cancers will spread has historically proven challenging, even for expert oncologists. This is because — as doctors have increasingly discovered over recent years — cancer is an heterogeneous disease, in which even single tumor cell demonstrates remarkable differences in behavior.

But a new computer model created by researchers has resulted in a fresh way to map cancer progression: possibly offering valuable life-saving insights as a result.

Study co-author Bud Mishra, professor at the Courant Institute of Mathematical Sciences of New York University, tells Digital Trends that existing cancer pathway models were inadequate for predicting how a tumor would metastasize. “We built our models based on model checking and probabilistic causation, which we had developed earlier in the context of hardware verification and data science,” he says.

Along with his co-author, biological machine learning expert Giulio Caravagna, what the pair’s model presents is a complex modeling system, called Pipeline for Cancer Inference — a.k.a. the cheerful-sounding PiCnIc. This modeling system uses gene sequencing data to form predictions about the conditions under which tumors grow. These includes oxygen and its lack thereof in the tumor environment, cell mobility, and immune response. All are taken into account by PiCnIc as it predicts how the tumor’s genomes will change over time. The model’s accuracy was tested against existing data about the growth of colorectal cancer, and passed with flying colors.

“Our algorithms have shown to achieve high accuracy, even in the presence of noise in the data, and with limited sample sizes,” Giulio Caravagna tells Digital Trends.

He says that the next step of the work is to develop techniques to deal with liquid biopsies and immunotherapy, drug resistance and the like.

“The field is moving towards an era of personalized medicine, in which treatments are tailored to individual patients based on their predicted response or risk of a disease,” Bud Mishra concludes. “Progression models have translational relevance, as they might allow to better predict tumor evolution, response to therapy, and identify markers for early diagnosis.”

In other words, when it comes to patient-driven healthcare, data science (and some very smart algorithms!) is your friend.

Editors' Recommendations

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
This algorithm can hide secret messages in regular-looking text
fontcode embeds messages in text screen shot 2018 04 11 at 18 38 28

FontCode: Embedding Information in Text Documents using Glyph Perturbation

Whether it’s hiding messages under the stamps on letters or writing in invisible ink, people have always found ingenious ways of using whatever technology they have available to write secret messages. A new project carried out by researchers at Columbia University continues this tradition by using some deep learning technology to embed encrypted messages in otherwise ordinary looking text.

Read more
Biotech startup is creating genetically engineered ‘superblood’ to battle cancer
mass produce red blood cells 11371807

cgtoolbox / 123RF Stock Photo
Rubius Therapeutics, a biotech startup that is creating “superblood” to treat a range of conditions including cancer, has raised an extra $100 million to make its dream a reality. Previously, the company raised $120 million from investors, thereby bringing its total haul close to the one quarter of a billion dollars mark -- all in less than one year.

Rubius is developing Red-Cell Therapeutics (RCT). These are genetically engineered, enucleated red cells which have been engineered to carry therapeutic proteins. Depending on the requirements, they can be loaded up with the necessary proteins to replace missing enzymes, kill tumors, and regulate the immune system for the battling of cancer and autoimmune diseases. They can then be transfused into patients to apply their healing powers.

Read more
Can an algorithm be racist? Spotting systemic oppression in the age of Google
algorithms of oppression racist opp featimg

Can a bridge be racist?
It sounds ridiculous, but that's exactly the argument sociologist Langdon Winner makes in “Do Artifacts Have Politics?” -- a classic essay in which he examines several bridges built over roadways in Long Island, New York.

Many of these bridges were extremely low, with just nine feet of clearance from the curb. Most people would be unlikely to attach any special meaning to their design, yet Winner suggested that they were actually an embodiment of the social and racist prejudices of designer Robert Moses, a man who was responsible for building many of the roads, parks, bridges, and other public works in New York between the 1920s and 1970s.

Read more